comparemela.com

Latest Breaking News On - Kiniksa pharmaceutical - Page 1 : comparemela.com

Analyst Estimates: Here s What Brokers Think Of Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) After Its First-Quarter Report

It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just.

Wedbush Weighs in on Kiniksa Pharmaceuticals, Ltd s Q1 2025 Earnings (NASDAQ:KNSA)

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for Kiniksa Pharmaceuticals in a research note issued to investors on Wednesday, February 28th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.17) per share for the quarter. Wedbush […]

Q1 2025 Earnings Estimate for Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) Issued By Wedbush

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Stock analysts at Wedbush issued their Q1 2025 EPS estimates for Kiniksa Pharmaceuticals in a research report issued on Wednesday, February 28th. Wedbush analyst D. Nierengarten forecasts that the company will post earnings per share of ($0.17) for the quarter. Wedbush currently has a “Outperform” rating and […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.